| Literature DB >> 35811083 |
Véronique Suttels1, Jacques Daniel Du Toit2, Arnauld Attannon Fiogbé3, Ablo Prudence Wachinou3, Brice Guendehou3, Frédéric Alovokpinhou3, Péricles Toukoui3, Aboudou Rassisou Hada3, Fadyl Sefou3, Prudence Vinasse3, Ginette Makpemikpa3, Diane Capo-Chichi3, Elena Garcia4, Thomas Brahier5, Kristina Keitel6, Khadidia Ouattara7, Yacouba Cissoko8, Seydina Alioune Beye9, Pierre-André Mans10, Gildas Agodokpessi3, Noémie Boillat-Blanco5, Mary Anne Hartley11.
Abstract
Point-of-care ultrasound (POCUS) is an increasingly accessible skill, allowing for the decentralization of its use to nonspecialist healthcare workers to guide routine clinical decision-making. The advent of ultrasound-on-a-chip has transformed the technology into a portable mobile health device. Because of its high sensitivity to detect small consolidations, pleural effusions, and subpleural nodules, POCUS has recently been proposed as a sputum-free likely triage tool for tuberculosis (TB). To make an objective assessment of the potential and limitations of POCUS in routine TB management, we present a Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis based on a review of the relevant literature and focusing on Sub-Saharan Africa (SSA). We identified numerous strengths and opportunities of POCUS for TB management, e.g., accessible, affordable, easy to use and maintain, expedited diagnosis, extrapulmonary TB detection, safer pleural/pericardial puncture, use in children/pregnant women/people living with HIV, targeted screening of TB contacts, monitoring TB sequelae, and creating artificial intelligence decision support. Weaknesses and external threats such as operator dependency, lack of visualization of central lung pathology, poor specificity, lack of impact assessments and data from SSA must be taken into consideration to ensure that the potential of the technology can be fully realized in research as in practice.Entities:
Keywords: Point-of-care ultrasound; Sub-Saharan Africa; Tuberculosis
Mesh:
Year: 2022 PMID: 35811083 DOI: 10.1016/j.ijid.2022.07.009
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 12.074